COVID-19 nanoMIPs for sensors


MIP Discovery’s ultra-high sensitivity COVID-19 nanoMIPs have been designed to detect the SARS-CoV-2 virus in rapid point of care devices.

  • Demonstrated an extremely low limit of detection of 5 fg/ml in a sensor device
  • 20 fold improvement to sensitivity when directly compared to commercial antibodies
  • No cross reactivity to coronavirus variants 299E, HKU1 or OC43

Technical Specification

  • Product Name: COVID-19 nanoMIP for sensors
  • Product Code: COV1001-B
  • Target: SARS-CoV-2 Coronavirus spike protein
  • Concentration: >0.1 mg/ml
  • Surface Functionality: Amine groups
  • Tested Applications: SPR, dot blot, electrochemical sensors